INTRODUCTIONIntrauterine insemination (IUI) is the therapeutic process of placing washed spermatozoa transcervically into the uterine cavity for the treatment of infertility. IUI theoretically allows a relatively higher number of motile spermatozoa to reach the oocyte and it has been used for a variety of indications such as non-severe male factor infertility, unexplained infertility, cervical mucus hostility, ovulatory disturbances, mild endometriosis, antisperm antibodies and male sexual dysfunctions like impotency, hypospadias, and retrograde ejaculation. [1][2][3][4] The rationale behind IUI is increasing the gamete density at the time and site of potential fertilization i.e., increasing the chances of spermatozoa meeting the oocyte in the fallopian tube after ovulation has occurred. IUI is generally considered as an intermediate step of low to moderate complexity before the application of more sophisticated assisted reproductive technologies (ART) such as IVF with or without ICSI.The overall success rates of IUI remains controversial and depends on several factors, with published pregnancy rates varying from as low as 5% to as high as 70% per patient, however a 10%-20% clinical pregnancies per cycle is an acceptable range for all aetiologies.2 The pregnancy rates per IUI cycle are quite variable in the literature due to differences in cause and duration of infertility, type of ovarian stimulation, sperm preparation techniques, treatment cycles and number of times IUI is performed during a cycle (single or double).
Results:The overall pregnancy rate was 15.2%. Among the predictive factors evaluated, the infertility diagnosis (PCO and male factor, p value <0.001), the post wash semen count (5-10 million, p value <0.001), type of IUI (double IUI over single IUI, p value <0.001) and the endometrial thickness on the day of trigger (9-10mm, χ2 =551.59 df =5 p<0.001) significantly influenced the pregnancy rate. Conclusions: IUI is a successful contemporary treatment for appropriately selected cases of PCO and male factor infertility, especially when female age is <35 years.